Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 25, 2018

Identifying Aerosolized Cyanobacteria as an Environmental Risk Factor for ALS using Human Bronchoalveolar Lavage and Nasal Swab Specimens (P4.449)

Dominic Facciponte, Matthew Bough, Jacob Rauh, James Carroll, Darius Seidler, John Dessaint, Louis Vaickus, Patricia Henegan, Tanya Butt, Angeline Andrew, Elijah Stommel
First published April 9, 2018,
Dominic Facciponte
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Bough
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Rauh
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Carroll
2Pulmonary Medicine, Dartmouth-Hitchcock Medical Center Lebanon NH United States
4Pulmonary Medicine, Geisel School of Medicine, Dartmouth Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darius Seidler
2Pulmonary Medicine, Dartmouth-Hitchcock Medical Center Lebanon NH United States
4Pulmonary Medicine, Geisel School of Medicine, Dartmouth Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Dessaint
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis Vaickus
3Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center Lebanon NH United States
5Pathology and Laboratory Medicine, Geisel School of Medicine, Dartmouth Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Henegan
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Butt
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angeline Andrew
7Neurology, Dartmouth Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elijah Stommel
1Neurology, Dartmouth-Hitchcock Medical Center Lebanon NH United States
6Neurology, Geisel School of Medicine, Dartmouth Lebanon NH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Identifying Aerosolized Cyanobacteria as an Environmental Risk Factor for ALS using Human Bronchoalveolar Lavage and Nasal Swab Specimens (P4.449)
Dominic Facciponte, Matthew Bough, Jacob Rauh, James Carroll, Darius Seidler, John Dessaint, Louis Vaickus, Patricia Henegan, Tanya Butt, Angeline Andrew, Elijah Stommel
Neurology Apr 2018, 90 (15 Supplement) P4.449;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To determine if aerosol is a potential route of cyanobacteria (CB) exposure in humans, and a possible risk factor for neurodegeneration in amyotrophic lateral sclerosis (ALS).

Background: Exposure to the CB toxin β-N-Methylamino-L-alanine (BMAA) has been implicated as an environmental risk factor for ALS. Our earlier epidemiologic studies of waterbodies with CB blooms in Northern New England suggest that inhalation of CB toxins may be a possible mode for human exposure.

Design/Methods: Seventeen non-ALS participants undergoing diagnostic bronchoscopy from Dartmouth-Hitchcock Medical Center consented to donate right upper lobe BALF and/or NS specimens. BALF samples were processed using standard cytocentrifuge methods and aliquots were reserved for nested 16s rDNA polymerase chain reaction (PCR). BALF and NS slides were analyzed using fluorescence microscopy (FM) to identify CB cells expressing phycocyanobilin pigments. “Fiji” software was used to analyze images for CB using a macro developed to measure fluorescent particles with ≥95% circularity for area and feret diameter. Purified CB was used as a positive control and analyzed following the same protocol as BALF and NS samples.

Results: 70.5% of BALF samples tested positive for CB using PCR. 91.6% of the PCR-positive BALF samples had CB detectable by FM, compared to only 20% of the PCR-negative samples. Independent samples t-tests found no significant differences between feret diameter of NS CB cells (Mean=2.85μm, SD=0.760μm) versus controls (Mean=3.19μm, SD=0.767μm); p= 0.486; and area of NS CB cells (Mean=4.48μm2, SD=2.91μm2) versus control CB cells (Mean=5.82μm2, SD=2.71μm2); p= 0.245.

Conclusions: These data suggest that humans may inhale aerosolized CB which can be harbored in the nostrils and, in some cases, the lungs. This is consistent with the hypothesis that aerosol may be a significant route of CB transmission. With chronic exposure, we postulate that this could represent an environmental risk factor for ALS.

Study Supported by: Diamond Research Development Award - Neurology, Dartmouth-Hitchcock Medical Center

Disclosure: Dr. Facciponte has nothing to disclose. Dr. Bough has nothing to disclose. Dr. Rauh has nothing to disclose. Dr. Carroll has nothing to disclose. Dr. Seidler has nothing to disclose. Dr. Dessaint has nothing to disclose. Dr. Vaickus has nothing to disclose. Dr. Henegan has nothing to disclose. Dr. Butt has nothing to disclose. Dr. Andrew has nothing to disclose. Dr. Stommel has nothing to disclose.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise